Publications by authors named "Emi Hamano"

Claim this Profile
F
FER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer.
Masanori Kawakami, Shigeki Morita, Mitsuhiro Sunohara, Yosuke Amano, Rie Ishikawa, Emi Hamano

Int J Clin Exp Pathol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of a common splice site polymorphism on the generation of OAS1 variants in human bronchial epithelial cells.
Satoshi Noguchi, Emi Hamano, Ikumi Matsushita, Minako Hijikata, Hideyuki Ito

Hum Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MxA transcripts with distinct first exons and modulation of gene expression levels by single-nucleotide polymorphisms in human bronchial epithelial cells.
Satoshi Noguchi, Minako Hijikata, Emi Hamano, Ikumi Matsushita, Hideyuki Ito

Immunogenetics· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
Kousuke Watanabe, Noriko Emoto, Emi Hamano, Mitsuhiro Sunohara, Masanori Kawakami

Int J Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CpG island methylation of microRNAs is associated with tumor size and recurrence of non-small-cell lung cancer.
Kentaro Kitano, Kousuke Watanabe, Noriko Emoto, Hidenori Kage, Emi Hamano

Cancer Sci· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of G0S2 as a gene frequently methylated in squamous lung cancer by combination of in silico and experimental approaches.
Masashi Kusakabe, Tomoko Kutomi, Kousuke Watanabe, Noriko Emoto, Naomi Aki, Emi Hamano

Int J Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan.
Yoshikazu Inoue, Koh Nakata, Toru Arai, Ryushi Tazawa, Emi Hamano

Respirology· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
Ryushi Tazawa, Emi Hamano, Toru Arai, Hiromitsu Ohta, Osamu Ishimoto

Am J Respir Crit Care Med· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population.
Emi Hamano, Minako Hijikata, Satoru Itoyama, Tran Quy, Nguyen Chi Phi

Biochem Biophys Res Commun· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF.
Toru Arai, Emi Hamano, Yoshikazu Inoue, Tazawa Ryushi, Toshihiro Nukiwa

Respir Med· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
Kanji Uchida, Koh Nakata, Bruce C Trapnell, Takahiro Terakawa, Emi Hamano

Blood· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis